Agilent Technologies, Inc.

New York Stock Exchange
Back to all articles
Bullish +55

Dimensional Fund Advisors LP Acquires 185,223 Shares of Agilent ...

📈 Dimensional Fund Advisors LP increased its Agilent holdings by 9.6% in Q1, adding 185,223 shares for a total stake of 2,108,764 shares valued at $240.3 million.

🏦 Massachusetts Financial Services Co. MA boosted its position by 13.8% to own 14.1 million shares worth $1.9 billion, while Mirae Asset Global Investments grew its stake by 20.9%.

💰 Agilent reported Q1 revenue of $1.83 billion, beating the consensus estimate of $1.80 billion and achieving a net margin of 19.55%.

📊 Earnings per share reached $1.49, surpassing the analyst consensus of $1.41, with year-over-year revenue growth of 10.0%.

🎯 Analysts maintain a 'Moderate Buy' rating with an average price target of $159.35, though HSBC recently lowered its target to $165 while maintaining a buy rating.

💵 The company paid a quarterly dividend of $0.255 on July 22nd, representing an annualized yield of 0.7% and a payout ratio of 20.48%.

📉 The stock trades at a PE ratio of 28.05 with a market capitalization of $39.45 billion and a debt-to-equity ratio of 0.43.

🔮 Management provided FY 2026 EPS guidance between $6.00 and $6.10, with Q3 2026 guidance set at $1.48 to $1.50 per share.

📈 The stock price opened at $139.68, trading above its 50-day moving average of $129.21 and 200-day moving average of $125.46.

🧬 Agilent operates as a global provider of scientific instrumentation for life sciences, diagnostics, and applied chemical markets with a diverse product portfolio.

Bullish Signals
  • Agilent Technologies beat quarterly revenue estimates by reporting $1.83 billion against a consensus of $1.80 billion.
  • The company achieved earnings per share of $1.49, exceeding the analyst consensus estimate of $1.41 by $0.08.
  • Revenue grew 10% year-over-year to $1.83 billion, demonstrating strong top-line momentum in its core markets.
  • Major institutional investors including Dimensional Fund Advisors and Massachusetts Financial Services Co. MA are increasing their stakes significantly.
  • The company maintains a healthy balance sheet with a current ratio of 2.10 and a low debt-to-equity ratio of 0.43.
  • Analysts have issued multiple buy and outperform ratings, with MarketBeat aggregating an average target price of $159.35.
  • The stock is trading above both its 50-day and 200-day moving averages, indicating positive short-to-medium-term technical trends.
  • Management provided clear forward guidance for FY 2026 EPS between $6.00 and $6.10, aligning with analyst expectations of $6.01.
Risk Factors
  • HSBC reduced its price target on Agilent Technologies from $180.00 to $165.00, indicating some analysts see limited upside at current levels.
  • Wells Fargo & Company lowered its price target from $165.00 to $160.00, suggesting a more conservative valuation outlook.
  • The stock has a 12-month high of $160.27 and is currently trading below that peak, reflecting recent consolidation or pullback in share price.
Full Analysis
Dimensional Fund Advisors LP increased its stake in Agilent Technologies by 9.6% during the first quarter, purchasing an additional 185,223 shares to hold a total of 2,108,764 shares valued at $240.3 million. Other major institutional investors also adjusted their positions, with Massachusetts Financial Services Co. MA significantly boosting its stake by 13.8% to own over 14.1 million shares worth nearly $1.9 billion, while Mitsubishi UFJ Asset Management and Mirae Asset Global Investments also increased their holdings. Analyst sentiment remains mixed but generally positive regarding the stock's valuation and growth prospects. Recent reports from HSBC, TD Cowen, Wells Fargo, Sanford C. Bernstein, and Royal Bank of Canada have issued buy or outperform ratings with target prices ranging from $153 to $180. MarketBeat aggregates these views into a 'Moderate Buy' rating with an average price target of $159.35, reflecting confidence in the company's scientific instrumentation business within life sciences and diagnostics markets. Financially, Agilent Technologies reported strong quarterly results with revenue of $1.83 billion, beating consensus estimates by 1.7%, and earnings per share of $1.49 versus an expected $1.41. The company achieved a net margin of 19.55% and returned to growth with revenue up 10% year-over-year. Management has provided forward guidance for fiscal 2026 EPS between $6.00 and $6.10, while the stock recently paid a quarterly dividend of $0.255, yielding approximately 0.7% on an annualized basis. The company maintains a solid balance sheet with a market capitalization of $39.45 billion, a PE ratio of 28.05, and healthy liquidity metrics including a current ratio of 2.10 and a debt-to-equity ratio of 0.43. With the stock trading above its 50-day and 200-day moving averages, institutional accumulation and positive earnings momentum suggest continued interest from value-oriented investors seeking exposure to laboratory automation and analytical solutions.